The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Meghalaya considers mandatory HIV/AIDS test before marriage following alarming rise in cases, aiming to benefit communities.

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Arizona organizations are working hard to provide testing and education for HIV/AIDS programs, but despite medical ...

A federal judge extended a block on an Idaho law that uses an applicant’s immigration status to determine whether they’re ...